Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chrystalina Antoniades

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Biomechanics|September 26, 2025
Comparative analysis of trunk sensor placement in people with and without Parkinson's diseaseCharalampos Sotirakis, Anna Pelliet, Niall Conway, et al.
Frontiers in Neurology|June 28, 2018
Effects of Deep Brain Stimulation on Eye Movements and Vestibular FunctionAasef G Shaikh, Chrystalina Antoniades, James Fitzgerald, et al.
Journal of Cognitive Neuroscience|March 1, 2018
Deep Brain Stimulation of the Subthalamic Nucleus Does Not Affect the Decrease of Decision Threshold during the Choice Process When There Is No Conflict, Time Pressure, or RewardFriederike Leimbach, Dejan Georgiev, Vladimir Litvak, et al.
NPJ Parkinson'S Disease|November 24, 2025
Daily steps are a predictor of, but perhaps not a risk factor for Parkinson's disease: findings from the UK BiobankAidan Acquah, Andrew Creagh, Valentin Hamy, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Daily steps are a predictor of, but perhaps not a modifiable risk factor for Parkinson's Disease: findings from the UK BiobankAidan Acquah, Andrew Creagh, Valentin Hamy, et al.
Vision Research|March 12, 2013
An internationally standardised antisaccade protocolChrystalina Antoniades, Ulrich Ettinger, Bertrand Gaymard, et al.
BMJ Open|July 29, 2025
Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and safety of oral atomoxetine for treating cognitive and behavioural changes in people with progressive supranuclear palsy syndromes in the UKRobert Durcan, Hugo Paula, Boyd C P Ghosh, et al.
Current Opinion in Neurology|June 17, 2026
Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and interventionAasef G Shaikh, Chrystalina Antoniades, Qadeer Arshad, et al.
NPJ Parkinson'S Disease|November 20, 2024
Accelerating Parkinson's Disease drug development with federated learning approachesAmit Khanna, Jamie Adams, Chrystalina Antoniades, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus StatementEmma Short, Ian M Adcock, Bilal Al-Sarireh, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Biomechanics|September 26, 2025
Comparative analysis of trunk sensor placement in people with and without Parkinson's diseaseCharalampos Sotirakis, Anna Pelliet, Niall Conway, et al.
Frontiers in Neurology|June 28, 2018
Effects of Deep Brain Stimulation on Eye Movements and Vestibular FunctionAasef G Shaikh, Chrystalina Antoniades, James Fitzgerald, et al.
Journal of Cognitive Neuroscience|March 1, 2018
Deep Brain Stimulation of the Subthalamic Nucleus Does Not Affect the Decrease of Decision Threshold during the Choice Process When There Is No Conflict, Time Pressure, or RewardFriederike Leimbach, Dejan Georgiev, Vladimir Litvak, et al.
NPJ Parkinson'S Disease|November 24, 2025
Daily steps are a predictor of, but perhaps not a risk factor for Parkinson's disease: findings from the UK BiobankAidan Acquah, Andrew Creagh, Valentin Hamy, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Daily steps are a predictor of, but perhaps not a modifiable risk factor for Parkinson's Disease: findings from the UK BiobankAidan Acquah, Andrew Creagh, Valentin Hamy, et al.
Vision Research|March 12, 2013
An internationally standardised antisaccade protocolChrystalina Antoniades, Ulrich Ettinger, Bertrand Gaymard, et al.
BMJ Open|July 29, 2025
Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and safety of oral atomoxetine for treating cognitive and behavioural changes in people with progressive supranuclear palsy syndromes in the UKRobert Durcan, Hugo Paula, Boyd C P Ghosh, et al.
Current Opinion in Neurology|June 17, 2026
Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and interventionAasef G Shaikh, Chrystalina Antoniades, Qadeer Arshad, et al.
NPJ Parkinson'S Disease|November 20, 2024
Accelerating Parkinson's Disease drug development with federated learning approachesAmit Khanna, Jamie Adams, Chrystalina Antoniades, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus StatementEmma Short, Ian M Adcock, Bilal Al-Sarireh, et al.
Pageof 1